UK-based life sciences firm Juvenescence has announced a $100m series B financing round to support the development of artificial intelligence (AI)-based therapeutics and technologies for ageing diseases.
InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019. This round of investment was co-led by Advantech Capital and CMBI, followed by Pudong Innotek. Also participating were exist